Home > National Drug Code (NDC) > Sandostatin LAR Depot

Sandostatin LAR Depot - 0078-0341-61 - (octreotide acetate)

Alphabetical Index


Drug Information of Sandostatin LAR Depot

Product NDC: 0078-0341
Proprietary Name: Sandostatin LAR Depot
Non Proprietary Name: octreotide acetate
Active Ingredient(s):    & nbsp;   octreotide acetate
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Sandostatin LAR Depot

Product NDC: 0078-0341
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021008
Marketing Category: NDA
Start Marketing Date: 19881101

Package Information of Sandostatin LAR Depot

Package NDC: 0078-0341-61
Package Description: 1 KIT in 1 KIT (0078-0341-61) * 2.5 mL in 1 SYRINGE * 1 SWAB in 1 PACKAGE * 5 mL in 1 VIAL, SINGLE-USE

NDC Information of Sandostatin LAR Depot

NDC Code 0078-0341-61
Proprietary Name Sandostatin LAR Depot
Package Description 1 KIT in 1 KIT (0078-0341-61) * 2.5 mL in 1 SYRINGE * 1 SWAB in 1 PACKAGE * 5 mL in 1 VIAL, SINGLE-USE
Product NDC 0078-0341
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name octreotide acetate
Dosage Form Name KIT
Route Name
Start Marketing Date 19881101
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Sandostatin LAR Depot


General Information